Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10811677rdf:typepubmed:Citationlld:pubmed
pubmed-article:10811677lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10811677lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:10811677lifeskim:mentionsumls-concept:C0014582lld:lifeskim
pubmed-article:10811677lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:10811677lifeskim:mentionsumls-concept:C0600688lld:lifeskim
pubmed-article:10811677lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:10811677lifeskim:mentionsumls-concept:C1519249lld:lifeskim
pubmed-article:10811677pubmed:issue10lld:pubmed
pubmed-article:10811677pubmed:dateCreated2000-6-15lld:pubmed
pubmed-article:10811677pubmed:abstractTextSequence-dependent clinical and pharmacokinetic interactions between paclitaxel and doxorubicin have been reported. Some data have shown an influence of paclitaxel on epirubicin metabolism, but no data are available about the effect of diverse sequences of these drugs. We investigated whether reversing the sequence of epirubicin and paclitaxel affects the pattern or degree of toxicity and pharmacokinetics.lld:pubmed
pubmed-article:10811677pubmed:languageenglld:pubmed
pubmed-article:10811677pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811677pubmed:citationSubsetIMlld:pubmed
pubmed-article:10811677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10811677pubmed:statusMEDLINElld:pubmed
pubmed-article:10811677pubmed:monthMaylld:pubmed
pubmed-article:10811677pubmed:issn0732-183Xlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:RossiLLlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:VenturiniMMlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:EspositoMMlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:BertelliGGlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:LunardiGGlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:VialeMMlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:VannozziM OMOlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:Del MastroLLlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:TolinoGGlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:AngioliniCClld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:StraneoMMlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:NumicoGGlld:pubmed
pubmed-article:10811677pubmed:authorpubmed-author:PastroneIIlld:pubmed
pubmed-article:10811677pubmed:issnTypePrintlld:pubmed
pubmed-article:10811677pubmed:volume18lld:pubmed
pubmed-article:10811677pubmed:ownerNLMlld:pubmed
pubmed-article:10811677pubmed:authorsCompleteYlld:pubmed
pubmed-article:10811677pubmed:pagination2116-25lld:pubmed
pubmed-article:10811677pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:meshHeadingpubmed-meshheading:10811677...lld:pubmed
pubmed-article:10811677pubmed:year2000lld:pubmed
pubmed-article:10811677pubmed:articleTitleSequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicity.lld:pubmed
pubmed-article:10811677pubmed:affiliationDepartment of Medical Oncology I and Pharmacotoxicology Laboratory, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy. mventur@hp380.ist.unige.itlld:pubmed
pubmed-article:10811677pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10811677pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811677lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811677lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811677lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811677lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10811677lld:pubmed